Combination of Umbralisib, Ublituximab, and Bendamustine Is Safe and Highly Active in Patients with Advanced Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
| Autor: | Lunning, Matthew A., Bierman, Philip, Bociek, R. Gregory, Schreeder, Marshall T., Siddiqi, Tanya, Flowers, Christopher R, Cohen, Jonathon B., Blumel, Susan *, Cutter, Kathy *, Pauli, Emily K. *, Sportelli, Peter, Miskin, Hari P *, Weiss, Michael S. *, Vose, Julie M. |
|---|---|
| Zdroj: | In Blood 29 November 2018 132 Supplement 1:4197-4197 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|